138 related articles for article (PubMed ID: 7979424)
1. [Treatment of prostatic carcinoma with UFT and leucovorin--basic study using SRCA].
Uchida K; Hayashi T; Shiga T; Hattori K; Nishijima Y; Kasaya S; Shimazui T; Akaza H; Koiso K; Nemoto R
Gan To Kagaku Ryoho; 1994 Nov; 21(15):2633-7. PubMed ID: 7979424
[TBL] [Abstract][Full Text] [Related]
2. [Subrenal capsule assay of nude mice for testing the effectiveness of UFT for rat prostatic carcinoma (R3327)].
Uchida K; Hayashi T; Nishijima Y; Kasaya T; Akaza H; Koiso K; Nemoto R; Harada M
Gan To Kagaku Ryoho; 1993 Feb; 20(2):229-33. PubMed ID: 8434960
[TBL] [Abstract][Full Text] [Related]
3. [Experimental study of UFT in prostatic carcinoma (DU-145) in nude mice].
Kagawa S; Takigawa H; Aga Y; Kurokawa K
Gan To Kagaku Ryoho; 1986 Dec; 13(12):3408-12. PubMed ID: 3098182
[TBL] [Abstract][Full Text] [Related]
4. [Results of the UFT sensitivity test using human urogenital cancers transplanted subcutaneously and under the subrenal capsule of nude mice].
Murahashi I; Honda M; Mukae K; Hosoya Y; Takasaki E
Gan To Kagaku Ryoho; 1988 Feb; 15(2):231-5. PubMed ID: 3124766
[TBL] [Abstract][Full Text] [Related]
5. [Effect of UFT with high dose leucovorin for transplantable bladder tumor (MBT-2) in mice].
Nishijima Y; Hinotsu S; Koiso K; Nemoto R
Gan To Kagaku Ryoho; 1991 Oct; 18(13):2349-51. PubMed ID: 1929454
[No Abstract] [Full Text] [Related]
6. Augmentation of the chemotherapeutic effectiveness of UFT, a combination of tegafur [1-(2-tetrahydrofuryl)-5-fluorouracil] with uracil, by oral l-leucovorin.
Okabe H; Toko T; Saito H; Nakano K; Fujioka A; Yuasa C; Takeda S; Unemi N
Anticancer Res; 1997; 17(1A):157-64. PubMed ID: 9066646
[TBL] [Abstract][Full Text] [Related]
7. [Combination chemotherapy with orally administered UFT and leucovorin (LV)].
Okabe H; Saito H; Oie S; Nakano K; Uchida J; Takechi T; Takeda S; Kawaguchi Y; Taguchi T
Gan To Kagaku Ryoho; 1991 Aug; 18(10):1645-50. PubMed ID: 1872623
[TBL] [Abstract][Full Text] [Related]
8. [In vivo chemosensitivity test for UFT and FT-207. I--Subrenal capsule assay].
Nishiyama M; Niimi K; Yamaguchi M; Hirabayashi N; Nosoh Y; Tohge T; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1987 Jan; 14(1):109-13. PubMed ID: 3099648
[TBL] [Abstract][Full Text] [Related]
9. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
Hoff PM; Pazdur R; Benner SE; Canetta R
Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH
Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517
[TBL] [Abstract][Full Text] [Related]
11. [Responsiveness of gynecological malignancies to oral antitumor agents in subrenal capsule assay and individualization of oral adjuvant chemotherapy].
Sekiguchi I; Suzuki M; Aida I; Tamada T; Nishida M
Nihon Sanka Fujinka Gakkai Zasshi; 1990 May; 42(5):437-42. PubMed ID: 2115558
[TBL] [Abstract][Full Text] [Related]
12. Antitumor efficacy of combination chemotherapy with UFT and cyclophosphamide against human breast cancer xenografts in nude mice.
Haga S; Shimizu T; Imamura H; Watanabe O; Kinoshita J; Fukushima M; Kajiwara T
Anticancer Res; 1999; 19(3A):1791-6. PubMed ID: 10470117
[TBL] [Abstract][Full Text] [Related]
13. [Augmentation of chemotherapeutic efficaciousness of UFT by oral l-leucovorin--l-leucovorin factors enhancing cytotoxic activity of 5-fluorouracil].
Yuasa C; Okabe H; Toko T; Takeda S; Unemi N
Gan To Kagaku Ryoho; 1995 Nov; 22(13):1927-32. PubMed ID: 7487122
[TBL] [Abstract][Full Text] [Related]
14. [Effect of UFT by oral administration using a murine hepatic metastasis model].
Yunoki S; Hizuta A; Sou J; Takahashi M; Nagata Y; Yamamoto M; Kataoka K; Matumoto M; Kawaguchi H; Miyagi K
Gan To Kagaku Ryoho; 1991 Sep; 18(12):2117-20. PubMed ID: 1888182
[TBL] [Abstract][Full Text] [Related]
15. [Antiproliferative and antimetastatic effects of UFT on MKL-4 human breast cancer cells transplanted into nude mice].
Kurebayashi J; Sonoo H
Gan To Kagaku Ryoho; 1995 Apr; 22(5):665-70. PubMed ID: 7717719
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of oral uracil/tegafur plus leucovorin in patients with hormone-refractory prostate carcinoma.
Bhandari MS; Pienta KJ; Fardig J; Olson K; Smith DC
Cancer; 2006 Apr; 106(8):1715-21. PubMed ID: 16534795
[TBL] [Abstract][Full Text] [Related]
17. [Experimental study on the combined treatment of UFT with etoposide against mouse Lewis lung carcinoma].
Takechi T; Nakano K; Uchida J; Takeda S
Gan To Kagaku Ryoho; 1993 Feb; 20(2):235-40. PubMed ID: 8434961
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of subrenal capsule assay (SRC) for clinical cancers].
Akao S; Iwami N; Oya M; Terada H; Sasaki K; Ishikawa H; Kiumi F
Gan To Kagaku Ryoho; 1996 Apr; 23(5):607-13. PubMed ID: 8678520
[TBL] [Abstract][Full Text] [Related]
19. Schedule-dependent synergism of vinorelbine and 5-fluorouracil/UFT against non-small cell lung cancer.
Matsumoto S; Igishi T; Hashimoto K; Kodani M; Shigeoka Y; Nakanishi H; Touge H; Kurai J; Makino H; Takeda K; Yasuda K; Hitsuda Y; Shimizu E
Int J Oncol; 2004 Nov; 25(5):1311-8. PubMed ID: 15492820
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between antitumor activity and the inhibition of thymidylate synthase after oral administration of UFT in nude mice bearing human tumor].
Fujita M; Fujita F; Uchida J; Takeda S; Yamada Y; Taguchi T
Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):627-32. PubMed ID: 2108611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]